Clinical trial
Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules
NCT04047186
Study timeline
Study start (actual)2019-07-01Date precision: day
Registry last updated2025-09-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Pulmonary Nodulesunresolved
Interventions
Tislelizumab InjectionDRUG · verified · RxNorm: tislelizumab Injection
Sponsors & collaborators
XiangNing Fulead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04047186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.